Cellular interactions in immune regulation. Hapten-specific suppression by non-T cells and T cell-mediated reversal of suppression by DeKruyff, RH et al.
CELLULAR  INTERACTIONS  IN  IMMUNE  REGULATION 
Hapten-specific Suppression by Non-T Cells 
and T  Cell-mediated Reversal of Suppression* 
BY ROSEMARIE  H.  DEKRUYFF,:~  BARRY  G.  SIMONSON, AND 
GREGORY  W.  SISKIND 
From the Division of Allergy and Immunology,  Department  of Medicine,  Cornell University Medical 
College, New  York 10021 
Evidence has accumulated in recent years that the immune system has the capacity 
for self-regulation. This can be visualized as limiting the expression of antigen-specific 
B  cells once an adequate  immune response has ensued.  The first clearly identified 
immunoregulatory activity involved serum antibody, which Uhr and co-workers (1, 
2) showed could operate to control the normal immune response. The importance of 
suppressor T  cells  in  immune  regulation  is  demonstrated  during  normal  immune 
responses (3, 4) as well as after tolerance induction  (5). Another proposed mechanism 
for  immunoregulation  is  an  autoanti-idiotype  response  in  which  there  is  specific 
recognition of the idiotypic determinants on the antigen-specific B and T  cells (6-8). 
The experiments presented  here were carried out  to characterize  the capacity of 
lymphoid cells from immunized animals to regulate the response of B cells from naive 
animals to the immunizing hapten.  Mice were immunized with  trinitropher~ylated 
(TNP) 1 bovine gamma globulin  (BGG)  in complete Freund's adjuvant  (CFA),  and 
their spleen cell population was analyzed at various times thereafter, both by mixed 
cell transfer and mixed cell culture experiments, for the presence of inhibitory activity, 
which affected the response to the TNP determinant. The inhibitory activity peaked 
1 wk after immunization, specifically affected the response to the TNP determinant, 
affected the response to both T-dependent and T-independent antigens, was active in 
vivo and in vitro, and appeared to be mediated by a specific non-T cell and modulated 
by T  cell activity.  In addition,  evidence is  presented  that  shows that  after antigen 
administration, T  cells are stimulated that are capable of abrogating suppression of 
the response to a T-independent antigen. 
* Supported in part by research grant AI-11694 from the National Institutes of Health, U. S. Public 
Health Service. 
Recipient of fellowshp 5F32 AI-05154 02 from the National Institutes of Health, U. S. Public Health 
Service. 
1  Abbreviations used in this paper: BGG, bovine gamma globulin; C, complement; CFA, complete Freund's 
adjuvant; FCS, fetal calf serum; PAA, polyacrylamide  beads; PFC, plaque-forming  cell(s); RAMB, rabbit 
anti-mouse brain antiserum; RAMIg, rabbit anti-mouse immunoglobulin antiserum; SIg, surface immu- 
noglobulin; SRBC, sheep erythrocytes; TNBSOs, 2,4,6-trinitrobenzene sulfonic acid, sodium salt; TNP, 
2,4,6-trinitrophenyl group; TNP-F, trinitrophenylated-lysine-Ficoll; TNP-PAA, trinitrophenylated poly- 
acrylamide beads. 
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Materials  and  Methods 
Animals.  LAFi mice were obtained  from  The Jackson  Laboratory, Bar  Harbor,  Maine. 
Adult  cell  transfer  recipients  and  donors  were  7-12  wk  old.  Spleen  donors  for  in  vitro 
experiments were 12-16 wk old. 
Antigens.  BGG was obtained as Fraction II from the Pentex division of Miles Laboratories 
Inc., Kankakee, Ill. TNP-BGG was prepared by the reaction of 2,4,6-trinitrobenzene sulfonic 
acid (TNBSOs; Eastman Organic Chemicals Div., Eastman Kodak Co., Rochester, N. Y.)  in 
0.28 M Na cacodylate, pH 7.2, for 1 h at room temperature, followed by extensive dialysis. The 
concentration of the conjugated protein was determined by dry weight analysis and its degree 
of derivitization was estimated spectrophotometrically from the absorbance at 348  nm  (e for 
TNP-lysine =  15,400).  The TNP-BGG preparation used in these experiments had  24 TNP 
groups per BGG molecule. Trinitrophenylated-lysine-Fieoll (TNP-F) was prepared by by the 
reaction of E-TNP-L-lysine HC1  (ICN Nutritional Biochemicals, Cleveland, Ohio) with Ficoll 
(400,000  mol  wt;  Pharmacia  Fine Chemicals,  Div.  of Pharmacia,  Inc.,  Piscataway,  N. J.) 
activated by cyanogen bromide at pH  10.0 for 24 h, followed by extensive dialysis. Trinitro- 
phenylated-polyacrylamide beads  (TNP-PAA)  were  prepared according to  the  methods  of 
Inman and Dintzis (9). The aminoethylated polyacrylamide was synthesized by the reaction of 
ethylenediamine (Sigma Chemical Co., St. Louis, Mo.) with Bio-gel-P30 (Bio-Rad Laboratories, 
Richmond, Calif.) for 30 min at 90°C.  The reaction was terminated by the addition of an 
equal volume of crushed ice, and the activated gel was washed extensively with 0.1 M  NaC1.  1 
g of the aminoethylated material in 30 ml of 0.09 M  sodium tetraborate, pH 9.3, was reacted 
with 3 mmol of TNBSOa at room temperature for 24 h. The product was extensively washed 
with 0.2 M  NaC1-Tris base and then with 0.2 M  NaCI. 
Cell Culture.  Primary antibody responses were elicited in culture as described by Mishell 
and  Dutton  (10),  using  the T-dependent  antigen,  sheep  erythrocytes  (SRBC),  and  the  T- 
independent antigen TNP-PAA.  Spleens were teased in  RPMI  1640,  passed through sterile 
gauze to remove clumps, washed twice, and resuspended in culture medium. Cells were cultured 
at  107 or 5 X  10  s cells per dish in modified minimal essential medium supplemented with  100 
U penicillin/ml, 10 #g streptomycin/ml, 2 mM glutamine, 5 ×  10 -s M 2-mercaptoethanol, and 
10%  fetal calf serum  (FCS). Cultures were "fed" daily, as described by Mishell and Dutton 
(10), and were rocked at 7 oscillations per minute in a humidified atmosphere of 10% CO2, 7% 
02, and 83% N2. 
Separation of Cells on Antibody-coated Dishes.  The basic technique used was that  devised by 
Mage et  al.  (11)  for selection of surface positive immunoglobulin  (SIg  +)  cells from  murine 
spleen  cells.  Purified  rabbit  anti-mouse  Ig  antibody  (RAMIg)  was  prepared  by  affinity 
chromatography of hyperimmune rabbit anti-mouse Ig antiserum on a mouse Ig-sepharose 4B 
(Pharmacia Fine Chemicals, Div. of Pharmacia Inc.) immunoadsorbent. After purification, the 
antibody was filtered and stored at 4°C as a  1 mg/ml solution in phosphate-buffered saline 
(PBS). To coat the plates (100-ram plastic dishes; 8-757; Fisher Scientific Co., Pittsburgh, Pa.) 
with Ig, 25/xg of this solution was diluted in  10 ml for each plate and incubated overnight at 
4°C. Plates were washed with PBS and then incubated for 1 h with 10 ml of PBS and 5% FCS. 
Plates were again washed, and 40 X  106 spleen cells in 10 ml PBS and 2% FCS was applied to 
each plate. After 1 h, the nonadherent  cells were removed, the plates were washed, and the 
adherent, SIg  + cells were flushed off the plates. 
Preparation of Supemate.  Mice were immunized by intraperitoneai injection of 500/~g TNP- 
BGG in CFA. 1 wk later, spleens were removed and cell suspensions were prepared, as previously 
described. Cells were cultured for 24 h  at  107 cells/ml in 60-mm tissue culture dishes (3002; 
Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) at 3 ml per dish. After 24 h, 
cultures were harvested and centrifuged. The supernate was filtered through a  0.45-#m  pore 
size filter (Millipore Corp., Bedford, Mass.). This supernate is termed immune S/N. Control 
supernate was prepared in a similar manner from spleen cells of normal mice that had not been 
immunized. 
Cell  Transfers.  In  all experiments,  LAFa adult  mice  were  lethally irradiated before  cell 
transfer by exposure to 800 rad from a gamma emitter. Spleens were teased in Hanks' balanced 
salt  solution,  passed  through  cotton  gauze  to  remove  clumps,  washed  twice  with  Hanks' 
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Immunization.  Mice were immunized by the intraperitoneal injection of 500/~g TNP-BGG 
emulsified in (2FA containing 2 mg/ml Mycobacterium butyricum in a  final volume of 0.2 ml. In 
some experiments, animals were immunized with 10/.tg TNP-F i.v. Cell transfer recipients were 
killed at various times after immunization, and their spleens were assayed for anti-TNP plaque- 
forming cells (PF(2). 
PFC Assay.  Anti-TNP PF(2 were determined by the Dresser and Greaves (12) slide modifi- 
cation of the Jerne plaque assay (13). TNP-conjugated SRB(2 were prepared by the reaction of 
TNBSOa with washed SRB(2, as described by Rittenberg and Pratt (14). Slides were incubated 
for 1 h at 37°(2.  Fresh-frozen guinea pig serum (absorbed with 50% packed SRB(2) was added 
at a final dilution of 1:30 as a source of complement ((2), and the slides were incubated for an 
additional 45 min. Detection of indirect anti-TNP plaques was effected by addition of rabbit 
anti-mouse Ig antiserum at a dilution that had been found to be optimal for plaque develop- 
ment. 
Antiserum Treatment.  In some experiments, the spleen cell population was depleted ofT cells 
by treatment  (at a concentration of 4-5 ×  107 cells/ml) with a  1:45 dilution of a rabbit anti- 
mouse brain antiserum  (RAMB) and (2. Agarose-absorbed guinea pig serum  (1:12 dilution) 
was used as the (2 source. The (2 had been shown to be nontoxic for mouse cells. The cells were 
incubated with antiserum plus (2 for 30 min at 37°(3  and were then washed three times. The 
RAMB was prepared by the method of Golub (15) and was absorbed with agarose, mouse bone 
marrow cells, and mouse kidney powder. The absorbed antiserum killed >95% of mouse thymus 
cells, <5% of mouse bone marrow cells, and ~40% of mouse spleen cells. It prevented mouse 
spleen cells from producing an in vitro proliferative response to phytohemagglutinin. 
Results 
Suppression of the Response to TNP-BGG by Spleen Cells from Mice Immunized with  TNP- 
BGG in CFA.  Mice were immunized with 500/.tg TNP-BGG  in CFA. These will be 
referred to as immune mice. Lethally irradiated mice were reconstituted with normal 
spleen cells, with immune spleen cells (obtained  1 wk after immunization), or with a 
mixture of normal and immune spleen cells. Recipients were immunized  1 d  after cell 
transfer with 500 #g TNP-BGG  in CFA. Animals were assayed for anti-TNP PFC at 
2 or 3 wk after cell transfer. The results are presented in Table I. Mice reconstituted 
with  immune  spleen  cells  gave  a  secondary  response,  characterized  by  a  greater 
number  of indirect  PFC,  an  increased ratio of indirect/direct PFC,  and  an  earlier 
peaking of the response as compared with mice reconstituted with naive spleen cells 
(compare assays done at 2 and 3 wk, experiment 2, Table I). However, when mixtures 
of normal and immune cells were transferred, the PFC response was markedly more 
depressed  than  was  expected.  This  was  especially  pronounced  at  2  wk  after  cell 
transfer. It should be noted that in all cases the response of the recipient of a  mixture 
of normal and immune cells was markedly lower than  that of recipients of immune 
cells alone, and in some cases it was even lower than the response of animals receiving 
only naive cells. Generally, both direct and indirect PFC responses were depressed in 
animals reconstituted with a  mixture of normal and immune cells. 
It should be mentioned that the peak of the primary PFC response of normal LAF1 
mice  to  TNP-BGG  in  CFA  has  been  previously shown  (16)  to  occur  7-9  d  after 
immunization.  In  the  present  studies,  immune  spleens were  assayed  for suppressor 
activity in  mixed  cell  transfer  experiments  at  1,  2,  and  3  wk  after  immunization. 
Suppressor activity was greatest at  1 wk after immunization (Table I), was decreased 
at 2 wk after immunization (Table II, experiment  1), and was not detectable at 3 wk 
after immunization (Table II, experiment 2). 
Suppression of the Response to TNP-F by Spleen Cells from Mice Immunized with TNP-BGG 
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TABLE  I 
Suppression of the Response to TNP-BGG by Spleen Cells  from Mice That Had Been 
Immunized with TNP-BGG 1 wk Previously* 
1191 
Experi-  Cells transferred:~  Time of 
ment  Normal  Immune  assay 
Anti-TNP PFC/spleen 
Direct  Indirect 
wk 
+  0  2  6,520  16,500 
0  +  4,950  76,200 
+  +  1,920  18,480 (P < 0.001) 
10 ×  10  7  0  2  24,600  53,500 
5 ×  107  0  16,970  32,850 
0  5 ×  107  6,650  72,520 
5 ×  107  5 ×  107  1,630  16,800 (P< 0.05) 
0  10 ×  107  4,620  120,550 
5× 107  10× 107  8,770  37,900 (P< 0.001) 
5 ×  107  0  3  7,000  69,000 
0  5 ×  107  5,350  59,250 
5 ×  107  5 ×  107  11,175  54,750 
* LAFx mice  were injected with 500 pg TNP-BGG i.p. in CFA. 1 wk later, cells from 
these "immune" mice, from normal mice, or mixtures of cells from immune and 
normal mice were transferred to irradiated recipients. The recipients were immu- 
nized with 500 #g TNP~-BGG in CFA 1 d after cell transfer and were assayed 2 or 
3 wk later, as indicated under "time of assay." Data are presented as the mean of 
results obtained on groups of four mice. Significance of differences were evaluated 
by the use of the Student's t test. The indirect PFC responses of recipients of a 
mixture of normal and immune cells were compared with responses of recipients of 
normal cells alone. 
:[: In experiment 1, the equivalent of one-half of a spleen of normal or immune mice 
was given per  recipient. In experiment 2,  the  indicated numbers of cells were 
transferred. 
CFA, 5 X  107 normal spleen cells, or mixtures of 5 X  107 normal and 5 ×  107 immune 
spleen cells were transferred into irradiated recipients that had received 800 rad 24 h 
previously. The recipients were challenged with  10 #g TNP-F i.v. on the day of cell 
transfer,  and  their  splenic anti-TNP PFC  were  assayed  7  d  later.  The  results  are 
presented  in  Table  III.  In  each  experiment,  mice  reconstituted  with  TNP-BGG 
immune spleen cells gave a  markedly lower response to the T-independent antigen 
TNP-F than did animals reconstituted with  naive spleen cells.  Mice  reconstituted 
with mixtures of normal and immune spleen cells gave anti-TNP responses to TNP- 
F  that were depressed by 38-67% as compared with those of mice reconstituted with 
only normal spleen cells.  In experiment 3,  immune spleen cells were  treated  with 
RAMB  plus  C  before  transfer.  This  treatment  did  not  affect  the  response of the 
immune cells. The response of mice reconstituted with normal plus RAMB-treated 
immune spleen cells was still suppressed (Table III). 
To rule out the possibility that the peak response of the immune population was 
missed by assaying only at  day  7,  a  transfer was performed  in which  groups were 
assayed  daily  from  3-7  d  after  antigen injection. There  was  no  difference  in  the 
magnitude of the PFC response of mice reconstituted with immune spleen cells from 
4-7  d  after  immunization. On  day  3  the  response  was  considerably lower.  The 1 192  HAPTEN-SPECIFIC SUPPRESSION  AND ABROSUPPRESSION 
TABLE II 
Suppression of the Response to TNP-BGG by Spleen Cells  from Mice That 
Had Been Immunized with  TNP-BGG 2 or 3 wk Previously  * 
Cells transferred  Time of  Experiment 
Normal  Immune  assay 
Anti-TNP PFC/spleen 
Direct  Indirect 
wk 
1~  +  0  2  14,633  37,400 
0  +  16,225  126,750 
+  +  7,675  100,350 
+  0  3  8,825  28,800 
0  +  4,900  60,900 
+  +  2,525  46,350 
2§  +  0  2  12,200  34,300 
0  +  4,350  85,400 
.+  +  15,320  87,300 
* LAF~ mice were injected with 500/~g TNP~4-BGG  i.p. in CFA. After 2 wk 
(experiment  1)  or  3 wk  (experiment 2),  5 ×  107 spleen cells from these 
"immune" mice, 5 ×  107 spleen cells from normal mice, or mixtures of spleen 
cells from both immune and normal mice (5 ×  107 each) were transferred to 
irradiated recipients. The recipients were immunized with 500 ~ug TNP24- 
BGG in CFA  1 d after cell transfer and were assayed 2 or 3 wk later, as 
indicated under "time of assay." Data are presented as the mean of results 
obtained on groups of four-five mice. 
:[: Transfer 2 wk postimmunization. 
§ Transfer 3 wk postimmunization. 
response of mice reconstituted with cells from normal donors peaked at  6-7 d  after 
immunization, and suppression was most pronounced when assayed at this time (data 
not shown). Essentially, no indirect plaques were detected in the response to TNP-F 
under the conditions of these experiments. 
To be certain that the suppressive activity was not the result of exposure to CFA, 
donors  were  immunized with  TNP-BGG  in  CFA  or  CFA  alone  before  transfer 
(experiment 2, Table III). The response by mice reconstituted with spleen cells from 
animals preimmunized with CFA alone is equivalent to the response of mice recon- 
stituted with  normal spleen cells.  Mixing cells from  mice preimmunized with CFA 
with cells from naive mice does not result in suppression of the response as compared 
with that of mice reconstituted only with cells from normal donors. 
Suppression of the In  Vitro Anti-TNP PFC Response by Immune Spleen  Cells.  Spleen cells 
from normal mice or from mice immunized 1 wk previously with TNP-BGG in CFA 
were challenged in vitro with SRBC or with the T-independent antigen TNP-PAA. 
A representative experiment is presented in Table IV. Spleen cells from immune mice 
produce far fewer  PFC  in response to TNP-PAA than do spleen cells from normal 
mice. Although the anti-SRBC response of immune spleen cells is somewhat  lower 
than that  of normal spleen cells in this experiment, the  response is still within the 
usual range of these cultures (Table V). When 5 ×  106 spleen cells from immune mice 
were mixed with 5  ×  10  s cells from normal mice, the anti-TNP-PAA response was 
suppressed  91%.  The  suppressive  activity was  TNP  specific  in  that  there  was  no 
suppression of the anti-SRBC response (Tables IV and V). Even 1 ×  106 spleen cells R.  H.  DEKRUYFF, B.  G.  SIMONSON, AND G. W.  SISKIND 
TABLE  III 
Suppression of the Response to TNP-F by Spleen Cells from Mice That Had 
Been Immunized with TNP-BGG* 
Cells transferred 
Experi-  Direct anti-TNP PFC:~ 
ment  Normal  Immune 
PFC/spleen 
+  0  47,300 
0  +  4,400 
+  +  29,000 (39%) P < 0.02 
+  0  45,800 
0  +  19,500 
+  -4-  15,000 (67%) P< 0.001 
0  CFA  48,000 N.S. 
+  CFA  56,000 (-22%) NS 
+  0  59,900 
0  +  13,400 
+  +  34,100 
0  RAMB  15,900 
+  RAMB  30,200 
(40%) P < 0.05 
* LAFI mice were injected with 500/zg TNP-BGG i.p. in CFA or with CFA 
alone. 1 wk later, 5 ×  107 spleen cells from these mice were transferred alone 
or together with 5 ×  107 normal spleen cells into recipients that had been 
given 800 rad 24 h previously. Mice were challenged with 10/~g  TNP-F i.v. 
at the time of cell transfer, and were assayed for anti-TNP PFC 7 d later. 
Data are presented as the mean of results with groups of four mice. 
:~ Numbers in parentheses indicate the percentage of suppression of the PFC 
response as compared with the response of mice reconstituted with normal 
spleen ceils alone. Significance of differences were evaluated by use of the 
Student's t test. 
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from  immune mice caused  marked  suppression of the  response of 5  X  106  normal 
spleen cells (Table IV). 
Experiments were carried out to characterize the nature of the suppressive activity 
(Table V). Spleen cells from either the immune or normal mice, or both, were treated 
with RAMB antiserum and C. All controls were treated with C  alone. The anti-TNP- 
PAA responses of mixtures of normal and immune spleen were suppressed  70-90%, 
calculated on the basis of simultaneous cultures of the  individual cell populations 
comprising the mixtures. RAMB antiserum and C  treatment of the immune spleen 
cell population did not alter the suppression. When the normal spleen cell population 
was treated with RAMB antiserum plus C  and mixed with immune spleen cells, the 
degree  of suppression was  significantly decreased,  although  it  was  not  eliminated. 
However, when RAMB plus C-treated immune cells were mixed with RAMB plus C- 
treated normal cells, the anti-TNP response was markedly suppressed. 
Comparable results were obtained when anti-Thy-1 was  used instead of RAMB 
antiserum. For example, in some experiments the immune spleen cells were treated 
with a  monoclonal anti-Thy-l.2 and C  instead of the  RAMB. The cells remaining 
after treatment were possibly enriched for suppressive activity (Table IV). Certainly, 
suppression was not eliminated by anti-Thy-1.2 treatment of the immune cell popu- 
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TABLE  IV 
Suppression of the In Vitro Anti- TNP PFC Response to TNP-PAA by Spleen Cells  from TNP- 
BGG-immunized Mice* 
Cells cultured 
Experi-  Direct anti-SRBC  Direct anti-TNP 
ment  Normal  Immune  PFC  PFC:I: 
PFC/culture  PFC/culture 
5 X  10  n  0  675  9,080 
1 ×  107  0  1,485  16,760 
0  1 ×  10  n  0  0 
0  2 ×  106  105  0 
0  5 ×  10  a  305  320 
5 ×  106  1 x  106  835  2,850 (69%) 
5 ×  106  2 ×  106  720  1,795  (80%) 
5 X  106  5 ×  106  880  850 (91%) 
5 ×  106  0  544  14,916 
0  5 ×  106  250  1,254 
5 X  106  5 ×  106  587  1,122  (92%) 
5 ×  106  2.5 ×  106  NDll  4,774 (68%) 
5 x  10  s  1.25 ×  106  ND  6,534 (56%) 
5 ×  106  2.5 ×  106 (anti-Thy-l.2)§  592  2,178 (85%) 
* Spleen ceils from 3- 4-mo-old normal or TNP-BGG-immune (1  wk after antigen in CFA)  mice 
were cultured for 4 d  with TNP-PAA or SRBC. Values represent direct anti-TNP or anti-SRBC 
plaque-forming cells per culture. Data from one experiment that is representative of three similar 
experiments are presented. 
:1: Numbers in  parentheses indicate  the percentage of suppression from the expected  response of 
mixed cultures. The expected response was calculated from the results of simultaneous cultures of 
the individual cell populations comprising the mixtures. 
§ In experiment 2, immune spleen cells (5  ×  107/ml) were treated  with monoclonal anti-Thy-l.2 
(final concentration  1:100,000)  and rabbit C  for 45 min at 37°C and washed. 2.5 ×  106 treated 
cells were added to the normal spleen cells where indicated. 
II Not done. 
TABLE  V 
Effect of RAMB Plus C Treatment of the Suppressive Activity of Immune Spleen Cells * 
Cells cultured 
Normal  Immune 
Direct anti-SRBC PFC  Direct anti-TNP PFC~ 
Experiment  1  Experiment 2  Experiment 3  Experiment  1  Experiment 2  Experiment  3 
PFC/culture  PFC/culture 
+  0  630  390  980  7,830  7,350  8,075 
0  +  1,050  1,314  770  680  450  2,365 
0  RAMB-treated  0  20  0  390  200  820 
+  +  1,338  1,760  1,838  885 (90%)  640 (92%)  3,115 (70%) 
+  RAMB-treated  903  390  890  585 (93%)  180 (9~%)  1,460 (84c7,) 
RAMB-treated  0  ND§  0  0  ND  5,930  6,800 
RAMB-treated  +  ND  3,060  2,330  ND  4,595 (28%)  5,315 (42%) 
RAMB-treated  RAMB-treated  ND  ND  0  ND  820 (87%)  1,190 (84%) 
* 5 ×  l0  s or 10 ×  1066 viable spleen cells were cultured for 4 d with SRBC or with TNP-PAA. Mixtures were composed of 5 ×  106 viable spleen 
cells of each of the indicated cell types. Normal spleen cells were obtained from 3- 4-mo-old mice. Immune spleen cells were obtained from 
mice immunized with TNP-BGG in CFA  1 wk before killing. To deplete spleens ofT cells, the cell suspensions were incubated at 4-5 ×  107 
cells/ml with RAMB antiserum (1:45 final concentration) plus agaro~-absorbed  guinea pig C  ( 1  : 12) at 37°C for 30 if, in. The cells were then 
washed three times, and the cells remaining after treatment  of 5  ×  10  ~ cells were added to each dish. Controls were treated with agarose- 
absorbed guinea pig C  (1:12). 
:~ Numbers  in parentheses  indicate the percentage of suppression  from  the expected  response of mixed cultures. The expected  response was 
calculated from the results of simultaneous cultures of the individual cell populations comprising the mixtures. 
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Because it has been reported (17) that in certain systems, specific suppressor T  cells 
may be resistant  to anti-theta antiserum and C  treatment, other purification steps 
were taken to analyze the nature of the suppressive activity. SIg  + cells were positively 
selected from the immune spleen cell population by panning on plastic dishes coated 
with RAMIg (Table VI). It was found that the SIg  ÷ cells were enriched for suppressive 
activity  compared  with  unseparated  immune  spleen  cells.  The  RAMIg  adherent 
spleen cells were then treated with anti-Ly-1,2 and C  to eliminate any remaining T 
cells.  These cells still suppressed the normal response (Table VI). 
Suppression  of the  In  Vitro  Anti-TNP  PFC Response  by  Supernate from  Immune  Spleen 
Cells.  The  following experiment  was  done  to  test  whether  a  soluble  suppressive 
substance was generated by the immune spleen cells. 7 d after immunization with 500 
#g TNP-BGG in CFA, spleen cells were put into culture without antigen. After 24 h, 
the cultures were centrifuged and  the supernate passed  through  a  Millipore mem- 
brane. This immune supernate was compared with the effect of supernates obtained 
simultaneously from cultures of spleen cells from unimmunized cells. At a concentra- 
tion of 50%  (~4 ×  106 cell equivalents)  the immune S/N suppressed the anti-TNP 
response of normal spleen cells (control response) by -50% (Table VII). Control S/N 
had either no effect or an enhancing effect on the control response. 
Discussion 
The  results  presented  here demonstrate  the  development of specific suppressive 
activity during the course of an immune response to TNP-BGG. This activity was 
effective in  depressing  the  in  vivo response to TNP on both T-dependent  and  T- 
independent carriers. When TNP-BGG immune spleen cells were transferred to an 
irradiated  mouse  and  challenged  with  TNP-BGG,  they  produced  a  characteristic 
secondary response.  Suppression  was  only evident  when  mixtures  of normal  and 
immune spleen cells were challenged, suggesting that induction of suppressive activity 
in the normal spleen cells might be taking place. However, when mice reconstituted 
with TNP-BGG immune spleen cells were challenged with TNP-F, the magnitude of 
TABLE VI 
Evidence That the Cells Responsible  for the Suppression Activity Are Not T Lymphocytes * 
Cells 
Group  added/  Direct anti-  Percentage of 
culture  TNP PFC  suppression 
PFC/culture  % 
Control response  --  9,868  -- 
Immune spleen cells  1 ×  106  4,208  57 
5 x  10  s  1,085  89 
RAMIg-adherent immune spleen cells  1 X  l06  2,431  75 
5 X  10  s  1,002  90 
RAMIg-adherent,  anti-Ly-l,2  plus  C-treated  immune  1 x  l06  1,250  87 
spleen cells  5 ×  106  552  94 
* SIg  ÷ cells from the immune spleen cell population were purified by adherence to RAMIg-coated plastic 
dishes. Immune spleen cells, SIg+-purified immune spleen cells, or anti-Ly-l,2 antiserum plus C-treated 
SIg+-purified immune spleen cells were added in the numbers indicated to 5 ×  10  6 normal spleen cells. 
The effect of the added  immune cells on the direct  anti-TNP PFC  response to TNP-PAA by normal 
spleen cells was determined after 4 d of culture with antigen. The data are presented as PFC/culture and 
percentage of suppression from the control response by normal spleen cells. 1196  HAPTEN-SPECIFIC SUPPRESSION  AND  ABROSUPPRESSION 
TABLE VII 
Suppression of the In  Vitro Anti- TNP PFC Response to TNP-PAA by Supernate 
from Cultured Immune Spleen Cells* 
Group 
Direct anti-TNP PFC 
Experiment  1  Experiment 2 
Control response  7,580  987 
10% Immune supernate  6,050 (19%)  ND:~ 
25% Immune supernate  5,300 (30%)  ND 
50% Immune supernate  3,780 (51%)  555 (44%) 
10% Control supernate  8,140 (-7%)  ND 
25% Control supernate  7,620  ND 
50% Control supernate  7,800 (-2%)  1,300 (-32%) 
* Spleen cells from 3-too-old normal  mice were cultured for 4 d  with TNP-PAA 
(control response). Where indicated, Miltipore-filtered supernate from 24-h cultures 
of immune or nonimmune  (control) spleen cells was added to the normal spleen cell 
cultures. Immune spleen cells were obtained 7 d after injection of 500 #g TNP-BGG 
i.p. in CFA. In experiment  1, 10 ×  100 cells were cultured in dishes, as described in 
Materials  and Methods. In experiment  2, cells were cultured in microtiter  plates 
(Falcon 3040) at 1 ×  10  ~ cells per well. Data in experiment  1 are given as PFC per 
culture and in experiment  2 as PFC per well (10  cells). Numbers in parentheses 
indicate the percentage of suppression of the control response. 
:1: Not done. 
their  anti-TNP  PFC  response  was  markedly  depressed  when  compared  with  mice 
reconstituted  with  normal  spleen  cells.  Suppression  of the  challenge  with  the  T- 
independent  antigen  was  readily demonstrated  by mixed cell transfer  experiments. 
The difference between these two sets of experiments lies in the challenge antigen. In 
the first group, it is probable that sufficient carrier (BGG)-specifie help was present to 
overcome  the  effects  of  the  suppressive  activity,  and  a  secondary  response  was 
obtained. When a  T-independent carrier (Ficoll) was used for challenge, the carrier- 
specific help was not operative, and the response of both the immune cells alone and 
the  mixture  of immune  and  normal  cells was  suppressed.  Comparable  results were 
also obtained in vitro studies. 
We believe that the cell responsible for suppression is a  B  cell because (a)  immune 
cells treated with RAMB and C  suppressed both the in vivo anti-TNP-F response and 
the  in  vitro TNP-PAA  response,  and  (b)  SIg plus cells obtained  from  the  immune 
population  by  elution  from  plastic  dishes  coated  with  RAMIg  were  enriched  for 
suppressive activity, and further treatment of these cells with anti-Ly- 1 and anti-Ly- 
2, and C  did not affect their suppressive activity. Because this population is relatively 
depleted  of macrophages  and  the  suppression  observed  was  antigen  specific,  it  is 
unlikely that macrophages are responsible for the suppression. However, we have not 
formally ruled out  a  role of the macrophages that could possibly passively carry the 
suppressive activity. Although the initial experiments were performed using an RAMB 
antiserum,  treatment  of immune  spleen  with  a  monoclonal  anti-theta  or  positive 
selection on anti-Ig-coated plates followed by treatment with anti-Ly-1,2 and C  also 
failed to eliminate the suppressive activity, which confirmed that it was not a  T  cell. 
The mechanism of suppression has not been characterized. Two possibilities exist. 
One is classical antibody feedback, that  is, the production of anti-TNP  antibody by 
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other possibility is anti-idiotypic antibody induced by the receptors of the immune B 
cells. The anti-idiotype antibody might bind the receptors of the assay B cells and 
inhibit antibody secretion. Precedents exist in the literature for both mechanisms (1, 
2, 18). A soluble specific suppressor factor was detected in the supernate from immune 
spleen cells cultured in the absence of antigen.  However, the suppressor factor was 
not  further characterized.  It  is  unlikely that  the  immune spleen contains  a  highly 
suppressive  antigen  fraction  because  such  "processed"  antigen  would  usually  be 
regarded as immunogenic. It would have to exert differential effects on normal and 
immune  cells  because  treatment  of normal  spleen  cells  with  RAMB  decreased 
suppression  when  immune  T  cells  were  present.  Furthermore,  the  activity  of the 
soluble suppressor factor was removed by incubation with antigen. 
Recently, Zubler et al. (19) have demonstrated that surface Ig-bearing, Ly-l-2-3-, 
B  lymphocytes, after  incubation  in  vitro with  SRBC,  could  exert  potent  specific 
suppressive effects on primary in vitro responses. There are many similarities between 
their system and  the one studied  here.  However, it must  be stressed that  we have 
shown that this regulatory mechanism operates in vivo as well as in vitro. That this 
mechanism  can  operate  in  vivo emphasizes  its  possible  importance in  the  normal 
regulation of the immune response. 
Characterization of the requirements for demonstration of suppressive activity in 
vitro suggests that its occurrence may be dependent upon complex interactions among 
different cell populations. Removal of T  cells from the immune spleen by incubation 
with RAMB antiserum and C did not decrease suppression. In contrast, removing T 
cells from the normal spleen cell population markedly reduced the suppressor activity, 
suggesting  that  an  interaction between immune spleen cells and  normal  T  cells is 
involved in generating suppressor activity. However, when T  cells were eliminated 
from  both  immune  and  normal  spleen  cell  preparations,  the  mixture  generated 
marked  suppressor  activity.  This  clearly  indicates  that  although  T  cells  may  be 
involved  in  regulating  the  degree  of suppression,  they  are  not  necessary  for  the 
generation or manifestation of suppressor activity in this system. 
The role of the T  cell in this system is interesting. It appears that the T  cells in the 
normal spleen cell population augment the suppression (i.e., their depletion decreases 
suppression),  whereas  T  cells  in  the  immune  spleen  cell  population  decrease  the 
suppression (i.e., their deletion, when T  cells have also been deleted from the normal 
spleen  cell  population,  increases  suppression).  Thus,  the  T  cell  population  in  the 
immune  spleen  acts  as  an  antagonist  of suppression.  We  would  suggest  the  term 
"abrosuppressor"  to  refer to  this  T  cell-mediated antagonism  of suppression.  The 
abrosuppressor does not appear to be a  traditional helper T  cell because it prevents 
the suppression of the response to a highly T-independent antigen (TNP-PAA). The 
term  "contrasuppressor" has  recently been proposed  (20)  to describe a  nonspecific 
activity generated upon culture of normal neonatal mouse spleen cells, which reversed 
the nonspecific suppressor activity generated upon culture of adult spleen cells. It was 
suggested that the contrasuppressor acted by rendering the helper T cell less responsive 
to suppression. The contrasuppressor appears to be distinct from what we are referring 
to as an abrosuppressor in that the latter activity is specific rather than nonspecific, 
and because it affects the responses to a T-independent antigen, it does not appear to 
act via an effect on helper T  cells. 
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which leads to the development of specific suppressor activity, is not obvious. It is 
possible that T  cells in the normal spleen cell population interact with the antigen- 
specific immune spleen cells to generate idiotype-specific suppressor T  cells (21). It is 
known that Ig-associated structures on activated B cells can trigger Ly-1+2  -  inducer 
cells to stimulate Ly-2  ÷ T  suppressor activity (22). Mechanisms such as these could 
explain  how  the  removal  of T  cells  from  the  normal  spleen  cell  population  can 
decrease suppression. 
It seems likely from much of the current literature in immunology that suppression 
is dominant  in the naive state of the immune system. That is,  the immune system 
normally exists  in  a  suppressed,  stable,  steady  state.  In  part,  the  stability  of this 
suppressed  state  appears  to  be  the  result  of a  network  of interactions  involving 
idiotypes and anti-idiotypes as suggested by .Jerne, and in part this suppressed stable 
state appears to result from a constant level of suppressor T  cell activity. On the basis 
of this line of reasoning, we would propose the hypothesis that  the initiation of an 
immune response involves temporarily abrogating this chronic state of suppression. 
The results reported here suggest that specific abrosuppressor cells can be stimulated 
by antigen  and  can  act  to  block suppressor  cell  activity.  It  is  suggested  that  the 
stimulation of specific abrosuppressor activity may be essential for the induction of an 
immune response to take place;  in its absence suppression would remain dominant 
and no immune response would occur. 
SummaFy 
The ability of lymphoid cells from immunized animals to regulate the response of 
naive  B  ceils to  the  immunizing hapten  was  studied.  Mice were  immunized  with 
trinitrophenylated  (TNP)  bovine  gamma  globulin  (BGG)  in  complete  Freund's 
adjuvant, and their spleen cells were examined in vivo and in vitro for the presence 
of  specific inhibitory activity. This activity was found to peak 1 wk after immunization, 
was active against TNP on both T-dependent (BGG) and T-independent (Ficoll and 
polyacrylamide beads)  carriers, and was demonstrable both by mixed cell transfers 
and mixed cell culture experiments. In in vitro studies, it was shown that the inhibition 
of the response to TNP-polyacrylamide beads by immune spleen cells was mediated 
by a  non-T cell, possibly a  B cell, because the suppressor activity was enriched in a 
purified B  cell preparation.  A  role for macrophages was  not  formally ruled out. A 
specific suppressor factor was produced in vitro by immune spleen cells cultured in 
the  absence of antigen.  The suppressor activity was  modulated by T .cells because 
elimination of T  cells from the normal spleen cell population decreased suppression; 
elimination of T  cells from the immune spleen cell population did not effect suppres- 
sion,  but  elimination  of T  cells  from  both  the  normal  and  immune  spleen  cell 
populations  allowed  the  expression  of marked  specific  suppression.  Thus,  T  cells 
present  in  the  normal  spleen  cell  population  augment  the  degree  of suppression, 
whereas T  cells present in the immune spleen cell population decrease the degree of 
suppression;  that  is,  T  cells present  in  the immune spleen cell population had  the 
ability to specifically abrogate suppression  ("abrosuppression")  in a  T-independent 
immune  response.  It  is  proposed  that  the  response  to  a  T-independent  antigen  is 
regulated by specific suppressor activity generated by a non-T cell and augmented by 
the interaction of this cell with a T  cell. The suppressor activity can be blocked by a 
specific abrosuppressor T cell. It is suggested that, because suppressor activity appears R.  H.  DEKRUYFF,  B. G.  SIMONSON,  AND G.  W.  SISKIND  | 199 
dominant in the naive state of the immune system, the induction of specific abrosup- 
pressor activity may be essential if an immune response is to take place. 
Received  for publication 17 February 1981 and in revised  form  17June 1981. 
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